Exhibit 16.1
July 17, 2023
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Ladies and Gentlemen:
We have read Elite Pharmaceuticals, Inc.’s statements included under Item 4.01 of its Form 8-K filed on July 17, 2023 and we agree with such statements concerning our firm.
Sincerely,
BUCHBINDER TUNICK & COMPANY LLP
150 Clove Road, 5th Floor ● Little Falls, NJ 07424 ● 862.496.6100
— With offices in New York and Maryland —